País: Austrália
Língua: inglês
Origem: Department of Health (Therapeutic Goods Administration)
Alendronate sodium
Scentia Pharmaceuticals Pty Ltd
Medicine Registered
Alendronate Sandoz 70mg tablets Consumer Medicine Information July 2011 ALENDRONATE SANDOZ ® ALENDRONATE SODIUM 70 MG TABLETS CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Alendronate Sandoz. It is particularly important that you read the section "When and how to take it" before you take this medicine. This leaflet does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risk of you taking this medicine against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT ALENDRONATE SANDOZ IS USED FOR Alendronate Sandoz is used to treat osteoporosis including osteoporosis caused by a group of medicines known as corticosteroids. This condition is caused by changes in the way bone is normally maintained. _UNDERSTANDING BONE _ Bone is living, growing tissue. Throughout life, our bodies are breaking down old bone and rebuilding new bone in a continuous cycle. Until our late 20s, while bones are still developing, we gain bone by building more than we lose. From then until about age 35 the process is usually in balance, so that the amount of bone lost is about equal to the amount that is replaced. After about age 35 this balance is disturbed, with bone loss occurring at a slightly faster rate than it can be replaced. In women, after menopause, hormonal changes cause bone loss at an even faster rate. When bone loss is excessive, bones can become thinner and weaker, and therefore Leia o documento completo
_Product Information _ _ _ _Page 1 of _18_ _ _Alendronate Sandoz 70 mg Tablets _ _August 2013 _ Version 03 Alendronate Sandoz Tablets PRODUCT INFORMATION ALENDRONATE SANDOZ 70 MG TABLETS NAME OF THE MEDICINE (4-amino-1-hydroxybutylidene) bisphosphonic acid monosodium salt trihydrate_. _ _ _ _Alendronate sodium _ _ _ _ _ _ _ _CAS [121268-17-5] _ _ _ _Empirical formula _ C 4 H 12 NNaO 7 P 2 .3H 2 0 MW:_ _325.12 DESCRIPTION Alendronate sodium is a white or almost white crystalline powder. It is soluble in water, very slightly soluble in methanol and practically insoluble in methylene chloride . Each Alendronate Sandoz tablet contains 91.4 mg of alendronate sodium, which is the molar equivalent to 70 mg of alendronic acid. _ _ In addition to the active ingredients, Alendronate Sandoz tablets contain the following inactive ingredients_ – _Microcrystalline cellulose, colloidal anhydrous silica, croscarmellose sodium and magnesium stearate. Alendronate Sandoz tablets are coated with Lustre Clear LC103 which contains microcrystalline cellulose, carrageenan and macrogol 8000._ _ _ _ _ _ PHARMACOLOGY Pharmacodynamics Alendronate is a bisphosphonate that, in animal studies, localises preferentially to sites of bone resorption, specifically under osteoclasts, and inhibits osteoclastic bone resorption with no direct effect on bone formation. Since bone formation and bone resorption are coupled, bone formation is also reduced, but less so than resorption, leading to progressive gains in bone mass (see Clinical Trials). Following exposure to alendronate, normal bone is formed that incorporates alendronate into its matrix, where it is pharmacologically inactive. The Leia o documento completo